介入治疗科普知识（Interventional therapy; popular science knowledge）.docVIP

介入治疗科普知识（Interventional therapy; popular science knowledge） Commonly used puncture site: femoral artery, brachial artery, axillary artery, carotid artery and so on, femoral artery is the most common. The veins include the femoral vein, the anterior cubital vein, the subclavian vein, the Uchi Shizu, and the external jugular vein. 9. what are the most common types of intra arterial infusion therapy? Problem list 1. primary and metastatic brain tumors. 2. primary malignant tumors of the maxillofacial region, such as nasopharyngeal carcinoma, tongue cancer, maxillary sinus cancer, gingival cancer, thyroid cancer, etc.. 3. breast malignancies, such as lung, esophageal, breast, and locally recurrent breast cancer. 4. abdominal malignant tumors, such as liver cancer, gastrointestinal cancer, pancreatic cancer, renal cell carcinoma, and multiple abdominal metastasis. 5. pelvic malignancies, such as bladder, rectal, ovarian, uterine, and pelvic metastases. 6. malignant tumors of bone and soft tissues, such as bone sarcoma, Ewings tumor, bone malignant tumor, bone metastasis tumor and various soft tissue malignant tumors. 10. what are the common adverse reactions and complications after interventional chemotherapy? Problem list The adverse reactions and complications of interventional chemotherapy including puncture site bleeding, hematoma, fever, pain, urinary retention, gastrointestinal reaction, liver dysfunction and bone marrow suppression, severe vascular stenosis and occlusion, nerve injury. 11. what are the contraindications of interventional chemotherapy? Problem list 1. have severe bleeding tendency. 2. patients with hepatic or renal dysfunction who are still refractory to appropriate treatment. 3. general physical state difference (bad fluid quality). 4. iodine hypersensitivity. 12. what preparations should be made before the tumor interventional treatment? Problem list 1. preoperative examination, such as blood routine, blood coagulation time, surface antigen, live